✦ LIBER ✦

Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases

✍ Scribed by Marrero Jorge A.; El- Serag Hashem B.

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 632 KB
Volume: 53
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.24033

No coin nor oath required. For personal study only.

✦ Synopsis

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

📜 SIMILAR VOLUMES

Postoperative transcatheter arterial che

Postoperative transcatheter arterial chemoembolization should be recommended in the hepatocellular carcinoma treatment guidelines of the American Association for the Study of Liver Diseases

✍ Zhidong Wang; Zongfang Li; Yuanyuan Ji 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views

We read with great interest the article by Martinot-Peignoux et al. 1 In this report from France, undetectable serum hepatitis C virus (HCV) RNA at 12 weeks (Wþ12) (409 patients) post-treatment follow-up was as relevant as undetectable serum HCV RNA at 24 weeks (Wþ24) (sustained virological response

Diagnosis and management of hemochromato

Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

✍ Bruce R. Bacon; Paul C. Adams; Kris V. Kowdley; Lawrie W. Powell; Anthony S. Tav 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 1 views

This guideline has been approved by the American Association for the Study of Liver Diseases (AASLD) and represents the position of the association. ## Preamble These recommendations provide a data-supported approach to establishing guidelines. They are based on the following: (1) a formal review

Management of patients with hepatitis C

Management of patients with hepatitis C virus genotype 2 or 3: Comments on updated american association for the study of liver diseases practice guidelines

✍ Olav Dalgard; Alessandra Mangia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

An analysis of the UNOS liver transplant

An analysis of the UNOS liver transplant registry: High serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma

✍ Nyingi Kemmer; Guy Neff; Tiffany Kaiser; Victoria Zacharias; Mark Thomas; Amit T 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

The current United Network for Organ Sharing (UNOS) criteria for liver transplantation gives priority to patients with elevated serum alpha-fetoprotein (AFP; Ն 500 ng/mL) in the absence of radiologic evidence of a hepatic mass. Reports have shown that an elevated serum AFP is a poor diagnostic indic

An update on treatment of genotype 1 chr

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

✍ Marc G. Ghany; David R. Nelson; Doris B. Strader; David L. Thomas; Leonard B. Se 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

American association for the study of li

American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis

✍ Marina G. Silveira; Elizabeth M. Brunt; Jenny Heathcote; Gregory J. Gores; Keith 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

A group of multidisciplinary experts on primary biliary cirrhosis (PBC) and its complications convened on May 31, 2009, under the aegis of the American Association for the Study of Liver Diseases (AASLD) in order to identify the most appropriate design and endpoints for clinical trials of PBC based